Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 May:9:e2400284.
doi: 10.1200/CCI-24-00284. Epub 2025 May 9.

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials

Affiliations
Clinical Trial

Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials

Mack Roach 3rd et al. JCO Clin Cancer Inform. 2025 May.

Abstract

Purpose: Artificial intelligence (AI) tools could improve clinical decision making or exacerbate inequities because of bias. African American (AA) men reportedly have a worse prognosis for prostate cancer (PCa) and are underrepresented in the development genomic biomarkers. We assess the generalizability of tools developed using a multimodal AI (MMAI) deep learning system using digital histopathology and clinical data from NRG/Radiation Therapy Oncology Group PCa trials across racial subgroups.

Methods: In total, 5,708 patients from five randomized phase III trials were included. Two MMAI algorithms were evaluated: (1) the distant metastasis (DM) MMAI model optimized to predict risk of DM, and (2) the PCa-specific mortality (PCSM) MMAI model optimized to focus on prediction death in the presence of DM (DDM). The prognostic performance of the MMAI algorithms was evaluated in AA and non-AA subgroups using time to DM (primary end point) and time to DDM (secondary end point). Exploratory end points included time to biochemical failure and overall survival with Fine-Gray or Cox proportional hazards models. Cumulative incidence estimates were computed for time-to-event end points and compared using Gray's test.

Results: There were 948 (16.6%) AA patients, 4,731 non-AA patients (82.9%), and 29 (0.5%) patients with unknown or missing race status. The DM-MMAI algorithm showed a strong prognostic signal for DM in the AA (subdistribution hazard ratio [sHR], 1.2 [95% CI, 1.0 to 1.3]; P = .007) and non-AA subgroups (sHR, 1.4 [95% CI, 1.3 to 1.5]; P < .001). Similarly, the PCSM-MMAI score showed a strong prognostic signal for DDM in both AA (sHR, 1.3 [95% CI, 1.1 to 1.5]; P = .001) and non-AA subgroups (sHR, 1.5 [95% CI, 1.4 to 1.6]; P < .001), with similar distributions of risk.

Conclusion: Using cooperative group data sets with a racially diverse population, the MMAI algorithm performed well across racial subgroups without evidence of algorithmic bias.

PubMed Disclaimer

References

    1. DeSantis CE, Miller KD, Goding Sauer A, et al. : Cancer statistics for African Americans, 2019. CA Cancer J Clin 69:211–233, 2019 - PubMed
    1. Badal S, Aiken W, Morrison B, et al. : Disparities in prostate cancer incidence and mortality rates: Solvable or not? Prostate 80:3–16, 2020 - PMC - PubMed
    1. Cuevas AG, Trudel-Fitzgerald C, Cofie L, et al. : Placing prostate cancer disparities within a psychosocial context: challenges and opportunities for future research. Cancer Causes Control 30:443–456, 2019 - PMC - PubMed
    1. Siegel DA, O’Neil ME, Richards TB, et al. : Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity - United States, 2001–2017. MMWR Morb Mortal Wkly Rep 69:1473–1480, 2020 - PMC - PubMed
    1. Cackowski FC, Mahal B, Heath EI, et al. : Evolution of Disparities in Prostate Cancer Treatment: Is This a New Normal? Am Soc Clin Oncol Educ Book 41:1–12, 2021 - PubMed

Publication types

LinkOut - more resources